Acambis plc (Acambis) (LSE: ACM, NASDAQ: ACAM) announces that it has submitted the first portion of a Biologics License Application (BLA) with the US Food and Drug Administration (FDA) to seek US licensure of its investigational smallpox vaccine, ACAM2000.
